[1] Reiss M, Sartorelli AC. Regulation of growth and differentiation of human keratinocytes by type beta transforming growth factor and epidermal growth factor. Cancer Res, 1987, 47: 6705-6709. [2] Hannon GJ, Beach D. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature, 1994, 371: 257-261. [3] Freathy C, Brown DG, Roberts RA, et al. Transforming growth factorbeta(1) induces apoptosis in rat FaO hepatoma cells via cytochrome c release and oligomerization of Apaf-1 to form an approximately 700-kd apoptosome caspase-processing complex. Hepatology, 2000,32: 750-760. [4] Cai JP, Falanga V, Taylor JR, et al. Transforming growth factor-beta differentially regulates the adhesiveness of normal and psoriatic dermal microvascular endothelial cells for peripheral blood mononuclear cells. J Invest Dermatol, 1992, 98: 405-409. [5] Cai JP, Falanga V, Taylor JR, et al. Transforming growth factor-beta receptor binding and function are decreased in psoriatic dermal endothelium. J Invest Dermatol, 1996, 106: 225-231. [6] 高春芳,郑茂荣,顾军,等.银屑病皮肤转化生长因子β原位表达的研究.中华皮肤科杂志,2001,34:124. [7] van de Kerkhof PC, Rulo HF, van Pelt JP, et al. Expression of endoglin in the transition between psoriatic uninvolved and involved skin. Acta Derm Venereol, 1998, 78:19-21. [8] Matsuura H, Myokai F, Arata J, et al. Expression of type Ⅱ transforming growth factor-beta receptor mRNA in human skin, as revealed by in situ hybridization. J Dermatol Sci, 1994, 8: 25-32. |